Piper Jaffray Upgrades Biogen (BIIB) to Overweight

November 7, 2016 7:14 AM EST
Get Alerts BIIB Hot Sheet
Price: $287.77 -0.61%

Rating Summary:
    18 Buy, 15 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade BIIB Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Piper Jaffray upgraded Biogen (NASDAQ: BIIB) from Neutral to Overweight with a price target of $335.00.

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $277.00 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades

Related Entities

Piper Jaffray

Add Your Comment